KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Cash from Operations (2017 - 2025)

Cardlytics (CDLX) has disclosed Cash from Operations for 9 consecutive years, with 13010000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 336.72% year-over-year to 13010000.0, compared with a TTM value of 9290000.0 through Dec 2025, up 205.28%, and an annual FY2025 reading of 9290000.0, up 205.28% over the prior year.
  • Cash from Operations was 13010000.0 for Q4 2025 at Cardlytics, up from 1761000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 13010000.0 in Q4 2025 and bottomed at 19691000.0 in Q1 2022.
  • Average Cash from Operations over 5 years is 4607300.0, with a median of 3616500.0 recorded in 2021.
  • The sharpest move saw Cash from Operations plummeted 2260.54% in 2022, then surged 336.72% in 2025.
  • Year by year, Cash from Operations stood at 555000.0 in 2021, then tumbled by 2260.54% to 13101000.0 in 2022, then surged by 122.4% to 2934000.0 in 2023, then increased by 1.53% to 2979000.0 in 2024, then soared by 336.72% to 13010000.0 in 2025.
  • Business Quant data shows Cash from Operations for CDLX at 13010000.0 in Q4 2025, 1761000.0 in Q3 2025, and 1225000.0 in Q2 2025.